PEAK6’s Bristol-Myers Squibb BMY Stock Holding History

PEAK6’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,126	Closed	-$882K	–	3034
2024 Q4	$856K	Buy	+15,126	New	+$845K	﹤0.01%	1893

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6's BMY Position: Q1 2025 in Review

PEAK6 sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 15,126 shares — an estimated $882K sold.

PEAK6 first reported a position in BMY in Q4 2024 and held it in 1 quarter. The position peaked at $856K in Q4 2024. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

PEAK6 reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
PEAK6 sold 15,126 Bristol-Myers Squibb shares in Q1 2025, an estimated $882K.
PEAK6 first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 1 quarter.
PEAK6's Bristol-Myers Squibb position peaked at $856K in Q4 2024.
2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on PEAK6's 13F filing for Q1 2025, filed 14 May 2025.